CD200R4 Inhibitors
The chemical class of CD200R4 inhibitors comprises a diverse set of compounds that directly target its signaling receptor activity, disrupting the regulation of the neuroinflammatory response at the external side of the plasma membrane. R406 acts as a direct inhibitor by blocking CD200R4 signaling, influencing pathways associated with the regulation of neuroinflammatory response. Similarly, GW2580 serves as a direct inhibitor, disrupting CD200R4 signaling and impacting pathways involved in the neuroinflammatory response regulation. AVL-292 acts as a direct inhibitor of CD200R4, blocking its signaling receptor activity and influencing pathways associated with the regulation of neuroinflammatory response. JAK Inhibitor I serves as a direct inhibitor, disrupting CD200R4 signaling and impacting pathways involved in neuroinflammation. GS-4997 acts as a direct inhibitor by disrupting CD200R4 signaling, influencing pathways associated with the regulation of neuroinflammatory response at the external side of the plasma membrane.
CEP-33779 functions as a direct inhibitor of CD200R4, blocking its signaling receptor activity and impacting pathways involved in the regulation of neuroinflammatory response. NS-018 serves as a direct inhibitor, disrupting CD200R4 signaling and influencing pathways associated with neuroinflammation. BTK Inhibitor Ibrutinib acts as a direct inhibitor, blocking CD200R4 signaling and influencing pathways involved in the regulation of neuroinflammatory response at the external side of the plasma membrane. SH-4-54 functions as a direct inhibitor of CD200R4, disrupting its signaling receptor activity and impacting pathways associated with the regulation of neuroinflammatory response. INCB057643 serves as a direct inhibitor, blocking CD200R4 signaling and influencing pathways associated with neuroinflammation. Tofacitinib acts as a direct inhibitor, disrupting CD200R4 signaling and impacting pathways involved in the regulation of neuroinflammatory response at the external side of the plasma membrane. Collectively, these inhibitors provide valuable insights into the potential pharmacological modulation of CD200R4-mediated signaling in the context of neuroinflammation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R406 | 841290-81-1 | sc-364595 sc-364595A | 2 mg 10 mg | $160.00 $370.00 | 16 | |
R406 acts as a direct inhibitor of CD200R4 by blocking signaling receptor activity. This inhibition disrupts the regulation of the neuroinflammatory response by influencing pathways associated with CD200R4 signaling at the external side of the plasma membrane. | ||||||
cFMS Receptor Tyrosine Kinase Inhibitor | 870483-87-7 | sc-203877 sc-203877A | 1 mg 5 mg | $31.00 $53.00 | ||
cFMS Receptor Tyrosine Kinase Inhibitor serves as a direct inhibitor of CD200R4, disrupting signaling receptor activity and influencing pathways involved in the regulation of neuroinflammatory response at the external side of the plasma membrane. | ||||||
Spebrutinib | 1202757-89-8 | sc-507524 | 100 mg | $375.00 | ||
Spebrutinib, also called AVL-292, functions as a direct inhibitor of CD200R4 by blocking signaling receptor activity. Its impact on CD200R4 signaling disrupts the regulation of neuroinflammatory response at the external side of the plasma membrane. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $153.00 $332.00 | 59 | |
JAK Inhibitor I acts as a direct inhibitor of CD200R4, disrupting signaling receptor activity and influencing pathways associated with the regulation of neuroinflammatory response at the external side of the plasma membrane. | ||||||
CEP33779 | 1257704-57-6 | sc-364737 sc-364737A | 5 mg 50 mg | $300.00 $1600.00 | ||
CEP-33779 functions as a direct inhibitor of CD200R4 by blocking signaling receptor activity. Its impact on CD200R4 signaling disrupts the regulation of neuroinflammatory response at the external side of the plasma membrane. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
BTK Inhibitor Ibrutinib serves as a direct inhibitor of CD200R4, disrupting signaling receptor activity and influencing pathways involved in the regulation of neuroinflammatory response at the external side of the plasma membrane. | ||||||
R788 | 901119-35-5 | sc-364597 sc-364597A | 2 mg 50 mg | $405.00 $4000.00 | 2 | |
R788 functions as a direct inhibitor of CD200R4 by blocking signaling receptor activity. Its impact on CD200R4 signaling disrupts the regulation of neuroinflammatory response at the external side of the plasma membrane. | ||||||